AGFiQ US Market Neutral Anti-Beta Fund’s (BTAL) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting AGFiQ US Market Neutral Anti-Beta Fund is a Sell.
AGFiQ US Market Neutral Anti-Beta Fund’s (BTAL) 20-Day exponential moving average is 14.08, making it a Sell.
AGFiQ US Market Neutral Anti-Beta Fund’s (BTAL) 50-Day exponential moving average is 14.22, making it a Sell.